Talk Bio

Actionable Insights Powered by AI

Subscribe

HER2-ultralow

FDA Approves Roche’s PATHWAY HER2 Test for HER2-Ultralow Metastatic Breast Cancer

talkbio0Tagged , , , , , , , , , ,

Roche, PATHWAY HER2 (4B5) test, FDA approval, HER2-ultralow, metastatic breast cancer, companion diagnostic, Enhertu, personalized medicine

Read More